RAPT Therapeutics Slips 9% After Pricing Public Offering

On:

Shares of RAPT Therapeutics, Inc. (RAPT) are down more than 9% Friday morning at $19.26.

The company today priced its public offering of 4,054,055 shares at $18.50 per share.

Gross proceeds of $75 million is estimated from the offering, which is expected to close on November 22.

RAPT has traded in the range of $9.85- $40.74 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Rockwell Climbs 7% As Earnings And Outlook Come In Better Than Consensus
  2. NYDIG Predicts Spot Bitcoin ETFs Could Unlock $30 Billion In Fresh Demand
  3. BMW Thailand To Use Blockchain Technology For Daily Operations
  4. Crypto Slide Unabated As Macros Hurt
  5. Crypto Markets Muted Ahead Of An Eventful Week